| [1] |
Papageorge MV, de Geus SWL, Woods AP, et al. Undertreatment of gallbladder cancer: a nationwide analysis[J]. Ann Surg Oncol, 2021, 28(6):2949-2957.
|
| [2] |
Shukla SK, Singh G, Shahi KS, et al. Staging, treatment, and future approaches of gallbladder carcinoma[J]. J Gastrointest Cancer, 2018, 49(1):9-15.
|
| [3] |
Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual[M]. 8th ed. Switzerland: Springer, 2017.
|
| [4] |
Nagino M, Hirano S, Yoshitomi H, et al. Clinical practice guidelines for the management of biliary tract cancers 2019: the 3rd English edition[J]. J Hepatobiliary Pancreat Sci, 2021, 28(1):26-54．
|
| [5] |
Goel M, Pandrowala S, Patel P, et al. Node positivity in T1b gallbladder cancer: a high volume centre experience[J]. Eur J Surg Oncol, 2022, 48(7):1585-1589.
|
| [6] |
Lee H, Kwon W, Han Y, et al. Optimal extent of surgery for early gallbladder cancer with regard to long-term survival: a meta-analysis[J]. J Hepatobiliary PancreatSci, 2018, 25(2):131-141.
|
| [7] |
Isambert M, Leux C, Métairie S, et al. Incidentally-discovered gallbladder cancer: when, why and which reoperation?[J]. J Visc Surg, 2011, 148(2):e77-84.
|
| [8] |
Alrawashdeh W, Kamarajah SK, Gujjuri RR, et al. Systematic review and meta-analysis of survival outcomes in T2a and T2b gallbladder cancers[J]. HPB, 2022, 24(6):789-796.
|
| [9] |
Chiba N, Shimazu M, Ochiai S, et al. Resection of hepatic lesions perfused by the cholecystic vein using indocyanine green navigation in patients with cT2 gallbladder cancer[J]. World J Surg, 2019, 43(2):608-614.
|
| [10] |
Shirai Y, Sakata J, Wakai T, et al. "Extended" radical cholecystectomy for gallbladder cancer: long-term outcomes, indications and limitations[J]. World J Gastroenterol, 2012, 18(34):4736-4743.
|
| [11] |
Higuchi R, Ota T, Araida T, et al. Surgical approaches to advanced gallbladder cancer: a 40-year single-institution study of prognostic factors and resectability[J]. Ann Surg Oncol, 2014, 21(13):4308-4316.
|
| [12] |
Shimada K, Nara S, Esaki M, et al. Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum[J]. Br J Surg, 2011, 98(1):117-123.
|
| [13] |
Torres OJM, Alikhanov R, Li J, et al. Extended liver surgery for gallbladder cancer revisited: is there a role for hepatopancreatoduodenectomy?[J]. Int J Surg, 2020(82S):82-86.
|
| [14] |
Søreide K, Guest RV, Harrison EM, et al. Systematic review of management of incidental gallbladder cancer after cholecystectomy[J]. Br J Surg, 2019, 106(1):32-45.
|
| [15] |
Cai W, Fan Y, Hu H, et al. Postoperative liver volume was accurately predicted by a medical image three dimensional visualization system in hepatectomy for liver cancer[J]. Surg Oncol, 2017, 26(2):188-194.
|
| [16] |
杨新伟, 杨平华, 张宝华, 等. 胆囊癌外科治疗的争议和体会[J]. 肝胆胰外科杂志, 2020, 32(1):1-5.
|
| [17] |
Le Roy B, Perrey A, Fontarensky M, et al. Combined preoperative portal and hepatic vein embolization (biembolization) to improve liver regeneration before major liver resection: a preliminary report[J]. World J Surg, 2017, 41(7):1848-1856.
|
| [18] |
Miura S, Kanno A, Fukase K, et al. Preoperative biliary drainage of the hepatic lobe to be resected does not affect liver hypertrophy after percutaneous transhepatic portal vein embolization[J]. Surg Endosc, 2020, 34(2):667-674.
|
| [19] |
Agarwal AK, Mandal S, Singh S, et al. Biliary obstruction in gallbladder cancer is not sine qua non of inoperability[J]. Ann Surg Oncol, 2007, 14(10):2831-2837.
|
| [20] |
Regimbeau JM, Fuks D, Bachellier P, et al. Prognostic value of jaundice in patients with gallbladder cancer by the AFCGBC-2009 study group[J]. Eur J Surg Oncol, 2011, 37(6):505-512.
|
| [21] |
Hawkins WG, DeMatteo RP, Jarnagin WR, et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer[J]. Ann Surg Oncol, 2004, 11(3):310-315.
|
| [22] |
Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection[J]. Ann Surg, 2011, 253(5):953-960.
|
| [23] |
Yang XW, Yang J, Li L, et al. Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent[J]. PLoS One, 2012, 7(12): e51513.
|
| [24] |
Yang XW, Chen JY, Wen ZJ, et al. Effect of preoperative jaundice on long-term prognosis of gallbladder carcinoma with radical resection[J]. World J Surg Oncol, 2020, 18(1):239.
|
| [25] |
Erdem S, White RR. Incidental gallbladder cancer: permission to operate[J]. Ann Surg Oncol, 2020, 27(4):980-982.
|
| [26] |
Lundgren L, Muszynska C, Ros A, et al. Management of incidental gallbladder cancer in a national cohort[J]. Br J Surg, 2019, 106(9):1216-1227.
|
| [27] |
Singh BP, Khan WF, Rathore YS, et al. Incidental carcinoma gallbladder: incidence, risk factors, and factors affecting survival-5-year experience from a tertiary care institute[J]. J Gastrointest Cancer, 2020, 51(3):980-987.
|
| [28] |
Ausania F, Tsirlis T, White SA, et al. Incidental pT2-T3 gallbladder cancer after a cholecystectomy: outcome of staging at 3 months prior to a radical resection[J]. HPB, 2013, 15(8):633-637.
|
| [29] |
Du J, Yang XW, Wen ZJ, et al. Relationship between prognosis and time interval from cholecystectomy to reoperation in postoperative incidental gallbladder carcinoma[J]. Chin Med J (Engl), 2018, 131(20):2503-2505.
|
| [30] |
范应方, 刘军, 张登明, 等. 腹腔镜胆囊癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(1):111.
|
| [31] |
Nag HH, Sachan A, Nekarakanti PK. Laparoscopic versus open extended cholecystectomy with bi-segmentectomy (s4b and s5) in patients with gallbladder cancer[J]. J Minim Access Surg, 2021, 17(1):21-27.
|
| [32] |
任泰, 李永盛, 耿亚军, 等. 中国2010-2017年胆囊癌治疗模式及预后分析[J]. 中华外科杂志, 2020, 58(9):697-706.
|